Loading quote...
NeoGenomics, Inc. (NEO) is a Medical - Diagnostics & Research company in the Healthcare sector listed on the NASDAQ Capital Market. The most recent ex-dividend date was December 17, 2020, with payment scheduled for December 30, 2020. market capitalization is approximately $208M.